1
|
Chaix B, Bista S, Wang L, Benmarhnia T, Dureau C, Duncan DT. MobiliSense cohort study protocol: do air pollution and noise exposure related to transport behaviour have short-term and longer-term health effects in Paris, France? BMJ Open 2022; 12:e048706. [PMID: 35361634 PMCID: PMC8971765 DOI: 10.1136/bmjopen-2021-048706] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Abstract
INTRODUCTION MobiliSense explores effects of air pollution and noise related to personal transport habits on respiratory and cardiovascular health. Its objectives are to quantify the contribution of personal transport/mobility to air pollution and noise exposures of individuals; to compare exposures in different transport modes; and to investigate whether total and transport-related personal exposures are associated with short-term and longer-term changes in respiratory and cardiovascular health. METHODS AND ANALYSIS MobiliSense uses sensors of location, behaviour, environmental nuisances and health in 290 census-sampled participants followed-up after 1/2 years with an identical sensor-based strategy. It addresses knowledge gaps by: (1) assessing transport behaviour over 6 days with GPS receivers and GPS-based mobility surveys; (2) considering personal exposures to both air pollution and noise and improving their characterisation (inhaled doses, noise frequency components, etc); (3) measuring respiratory and cardiovascular outcomes (smartphone-assessed respiratory symptoms, lung function with spirometry, resting blood pressure, ambulatory brachial/central blood pressure, arterial stiffness and heart rate variability) and (4) investigating short-term and longer-term (over 1-2 years) effects of transport. ETHICS AND DISSEMINATION The sampling and data collection protocol was approved by the National Council for Statistical Information, the French Data Protection Authority and the Ethical Committee of Inserm. Our final aim is to determine, for communicating with policy-makers, how scenarios of changes in personal transport behaviour affect individual exposure and health.
Collapse
Affiliation(s)
- Basile Chaix
- Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Nemesis team, INSERM, Paris, France
| | - Sanjeev Bista
- Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Nemesis team, INSERM, Paris, France
| | - Limin Wang
- Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Nemesis team, INSERM, Paris, France
| | - Tarik Benmarhnia
- Department of Family Medicine and Public Health & Scripps Institution of Oceanography, University of California San Diego, La Jolla, California, USA
| | - Clélie Dureau
- Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Nemesis team, INSERM, Paris, France
| | - Dustin T Duncan
- Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA
| |
Collapse
|
2
|
Bista S, Dureau C, Chaix B. Personal exposure to concentrations and inhalation of black carbon according to transport mode use: The MobiliSense sensor-based study. Environ Int 2022; 158:106990. [PMID: 34991251 DOI: 10.1016/j.envint.2021.106990] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Revised: 10/19/2021] [Accepted: 11/16/2021] [Indexed: 06/14/2023]
Abstract
INTRODUCTION Epidemiological evidence suggests that motorized vehicle users have a higher air pollutant exposure (especially from vehicle exhaust) than active (walking or cycling) transport users. However, studies often relied on insufficiently diverse sample and ignored that minute ventilation has an effect on individuals' inhaled dose. This study examined commuters' breathing zone concentration and inhaled doses of black carbon (BC) when travelling by different transport modes in the Grand Paris region. METHODS Personal exposure to BC was continuously measured with MicroAethalometer (MicroAeth AE51) portable monitors strapped on participants' shoulder with tube inlet at the level of the neck (breathing zone), and inhaled doses were derived from several methods estimating ventilation [based on metabolic equivalents from accelerometry [METs], heart rate, and breathing rate]. Trip stages and transport modes were assessed from GPS and mobility survey data. Breathing zone concentrations and inhaled doses of BC were compared across transport modes at the trip stage level (n = 7495 for 283 participants) using linear mixed effect models with a random intercept at individual level. RESULTS Trip stages involving public transport and private motorized transport were associated with a 2.20 µg/m3 (95% CI: 1.99, 2.41) and 2.29 µg/m3 (95% CI: 2.10, 2.48) higher breathing zone concentration to BC than walking, respectively. Trip stages with other active modes had a 0.41 µg (95% CI: 0.25, 0.57) higher inhaled dose, while those involving public transport and private motorized transport had a 0.25 µg (95% CI: -0.35, -0.15) and 0.19 µg (95 %CI: -0.28, -0.10) lower inhaled dose of BC per 30 min than walking. CONCLUSION The ranking of transport modes in terms of personal exposure was markedly different when breathing zone concentrations and inhaled doses were considered. Future studies should take both into account to explore the relationship of air pollutants in transport microenvironments with physiological response.
Collapse
Affiliation(s)
- Sanjeev Bista
- Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Nemesis team, Faculté de Médecine Saint-Antoine, 27 rue Chaligny, 75012 Paris, France.
| | - Clélie Dureau
- Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Nemesis team, Faculté de Médecine Saint-Antoine, 27 rue Chaligny, 75012 Paris, France
| | - Basile Chaix
- Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Nemesis team, Faculté de Médecine Saint-Antoine, 27 rue Chaligny, 75012 Paris, France
| |
Collapse
|
3
|
|
4
|
Droz C, Dureau C, Thomas D, Danchin N, Tricoire J, Benichou J, Paillard F, Hercberg S, Sibon I, Rouanet F, Rambelomanana S, Maizi H, Bernard MA, Blin P, Moore N. The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort). Value Health 2014; 17:A476. [PMID: 27201378 DOI: 10.1016/j.jval.2014.08.1366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- C Droz
- INSERM CIC Bordeaux CIC 1401, Univ. Bordeaux, INSERM U657, Bordeaux, France
| | - C Dureau
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - D Thomas
- Hôpital Pitié Salpétrière, Paris, France
| | - N Danchin
- Hôpital Européen Georges Pompidou, Paris, France
| | - J Tricoire
- Clinique Ambroise Paré, Toulouse, France
| | - J Benichou
- CHU de Rouen, INSERM U657, Rouen, France
| | | | | | - I Sibon
- CHU de Bordeaux, Bordeaux, France
| | | | - S Rambelomanana
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - H Maizi
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - M A Bernard
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - P Blin
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - N Moore
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, INSERM U657, CHU Bordeaux, Bordeaux, France
| |
Collapse
|
5
|
Blin P, Dureau C, Lamarque S, Bernard MA, Robinson P, Lassalle R, Grolleau A, Droz C, Moore N. Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in France. Value Health 2014; 17:A649. [PMID: 27202339 DOI: 10.1016/j.jval.2014.08.2357] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- P Blin
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - C Dureau
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - S Lamarque
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - M A Bernard
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - P Robinson
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - R Lassalle
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - A Grolleau
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - C Droz
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, Bordeaux, France
| | - N Moore
- INSERM CIC Bordeaux CIC1401, Univ. Bordeaux, INSERM U657, CHU Bordeaux, Bordeaux, France
| |
Collapse
|
6
|
Droz-Perroteau RLC, Dureau C, Caroline, Grelaud A, Angela, Rouyer M, Magali, Lignot S, Séverine, Fourrier-Réglat A, Blin P, Moore N. Analyse des données de l’Assurance maladie appliquée aux études de pharmaco-épidémiologie : exemples illustrés. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
7
|
Blin P, Dureau C, Grolleau A, Corbillon E, Jové J, Lassalle R, Poutignac N, Foubert-Samier A, Droz C, Moore N. Estimation de la prévalence et de l’incidence de la maladie de Parkinson en France à partir de l’échantillon généraliste des bénéficiaires. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
8
|
Droz-Perroteau C, Blin P, Dureau C, Lignot S, Bernard MA, Jové J, Lassalle R, Fourrier A, Moore N. Choix des critères en pharmaco-épidémiologie : intérêt de la persistance des traitements comme mesure d’impact des médicaments en situation réelle d’utilisation. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
9
|
Blin P, Dureau C, Lamarque S, Bernard MA, Robinson P, Lassalle R, Grolleau A, Droz C, Moore N. Mésusage, abus et détournement d’Instanyl® (fentanyl par voie nasale) en France. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
10
|
Droz C, Dureau C, Thomas D, Blin P, Moore N. Impact à 3,5ans des traitements recommandés en prévention secondaire de l’infarctus du myocarde sur la mortalité totale (Analyse intermédiaire de la cohorte EOLE). Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
11
|
Droz C, Blin P, Dureau C, Lignot S, Bernard MA, Jové J, Lassalle R, Fourrier A, Moore N. Choix des critères d’évaluation en pharmaco-épidémiologie : intérêt de la persistance des traitements comme mesure d’impact des médicaments en situation réelle d’utilisation. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2013.11.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
12
|
Droz C, Dureau C, Thomas D, Danchin N, Tricoire J, Bénichou J, Paillard F, Hercberg S, Sibon I, Rouanet F, Rambelomanana S, Maïzi H, Bernard MA, Blin P, Moore N. Impact à 3,5ans des traitements recommandés en prévention secondaire de l’infarctus du myocarde sur la mortalité totale (analyse intermédiaire de la cohorte Eole). Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2013.11.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
13
|
Blin P, Dureau C, Grolleau A, Corbillon E, Jové J, Lassalle R, Poutignat N, Foubert-Samier A, Droz C, Moore N. Estimation de la prévalence et de l’incidence de la maladie de Parkinson en France à partir de l’Échantillon généraliste de bénéficiaires. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2013.11.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
14
|
Droz C, Dureau C, Thomas D, Blin P, Moore N. Impact à 3,5ans des traitements recommandés en prévention secondaire de l’infarctus du myocarde sur la mortalité. Rev Epidemiol Sante Publique 2013. [DOI: 10.1016/j.respe.2013.07.264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
15
|
Droz C, Dureau C, Thomas D, Danchin N, Tricoire J, Bénichou J, Paillard F, Hercberg S, Sibon I, Rouanet F, Rambelomanana S, Maïzi H, Bernard MA, Blin P, Moore N. PP090—The 3.5-year mortality impact of drugs in secondary prevention of myocardial infarction in real-life (interim analysis of the eole cohort). Clin Ther 2013. [DOI: 10.1016/j.clinthera.2013.07.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Droz C, Dureau C, Thomas D, Danchin N, Tricoire J, Bénichou J, Paillard F, Ducimetière P, Hercberg S, Maïzi H, Bernard MA, Blin P, Moore N. Utilisation des traitements de prévention secondaire recommandés après hospitalisation pour infarctus du myocarde et après six mois de suivi : résultats de la cohorte EOLE. Rev Epidemiol Sante Publique 2011. [DOI: 10.1016/j.respe.2011.08.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022] Open
|
17
|
Dureau C, Droz C, Thomas D, Danchin N, Tricoire J, Bénichou J, Paillard F, Ducimetière P, Hercberg S, Maïzi H, Guiard E, Bernard MA, Blin P, Moore N. La prescription d’oméga 3 après un infarctus du myocarde modifie-t-elle l’adhésion aux règles hygiéno-diététiques ? Résultats de la cohorte EOLE. Rev Epidemiol Sante Publique 2011. [DOI: 10.1016/j.respe.2011.08.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
18
|
Droz C, Dureau C, Vespignani H, Marchal C, Jové J, Moore N, Fourrier-Réglat A. Efficacité et utilisation du lévétiracétam en vie réelle chez l’adulte en France, l’étude EULEV. Rev Epidemiol Sante Publique 2009. [DOI: 10.1016/j.respe.2009.07.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
19
|
Dureau C, Low M. The politics of knowledge: science, race and evolution in Asia and the Pacific. Hist Anthropol Chur 1999; 11:131-156. [PMID: 21265232 DOI: 10.1080/02757206.1999.9960911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
|